Studies on the properties of these “stem” cells in ovarian cancer using an Aldefluor assay to isolate ALDH1-bright (ALDH1br) cells from epithelial ovarian cancer cell lines, revealed greater stem-like properties, an enrichment in CD44, and association with chemoresistance and poor clinical outcome [62]. This evidence concerns the gene CD44 and ovarian carcinoma.